Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mukai

Showing results (51-60 of 273) with videos related to

Pageof 28
Sort By:
Endoscopy|February 1, 1993
Staging of pancreatic carcinoma by endoscopic ultrasonographyK Yasuda, H Mukai, M Nakajima, et al.
Journal of Abnormal Child Psychology|September 1, 1979
Children at risk for delinquency: a follow-up comparison of aggressive children and children who stealD R Moore, P Chamberlain, L H Mukai
Biochemical and Biophysical Research Communications|December 5, 1998
The role of PKN in the regulation of alphaB-crystallin expression via heat shock transcription factor 1M Kitagawa, H Mukai, M Takahashi, et al.
Arzneimittel-Forschung|December 22, 1999
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105H Mukai, T Sugimoto, M Ago, et al.
Applied and Environmental Microbiology|September 1, 1981
Transformation of bile acids by Clostridium perfringensS Hirano, N Masuda, H Oda, et al.
The Journal of Antibiotics|February 1, 1986
Biological properties of streptonigrin derivatives. II. Inhibition of reverse transcriptase activityH Okada, H Mukai, Y Inouye, et al.
The Journal of Investigative Dermatology|April 1, 1988
Differential staining of skin-limited amyloid and colloid bodies with immunofluorescence after pretreatmentsH Mukai, H Eto, S Nishiyama, et al.
International Journal of Pharmaceutics|September 16, 1999
Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist, at therapeutic doses in several animal species and interspecies scaling of its pharmacokinetic parametersH Mukai, S Watanabe, K Tsuchida, et al.
Protein and Peptide Letters|November 11, 2008
Elucidation of structural requirements of mastoparan for mast cell activation-toward the comprehensive prediction of cryptides acting on mast cellsH Mukai, Y Suzuki, Y Kiso, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|August 1, 1990
[The role of bacteria on facial rosacea-like dermatitis in adult type atopic dermatitis]T Noguchi, H Mukai, K Nishioka, et al.
Pageof 28

Showing results (51-60 of 273) with videos related to

Sort By:
Pageof 28
Endoscopy|February 1, 1993
Staging of pancreatic carcinoma by endoscopic ultrasonographyK Yasuda, H Mukai, M Nakajima, et al.
Journal of Abnormal Child Psychology|September 1, 1979
Children at risk for delinquency: a follow-up comparison of aggressive children and children who stealD R Moore, P Chamberlain, L H Mukai
Biochemical and Biophysical Research Communications|December 5, 1998
The role of PKN in the regulation of alphaB-crystallin expression via heat shock transcription factor 1M Kitagawa, H Mukai, M Takahashi, et al.
Arzneimittel-Forschung|December 22, 1999
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105H Mukai, T Sugimoto, M Ago, et al.
Applied and Environmental Microbiology|September 1, 1981
Transformation of bile acids by Clostridium perfringensS Hirano, N Masuda, H Oda, et al.
The Journal of Antibiotics|February 1, 1986
Biological properties of streptonigrin derivatives. II. Inhibition of reverse transcriptase activityH Okada, H Mukai, Y Inouye, et al.
The Journal of Investigative Dermatology|April 1, 1988
Differential staining of skin-limited amyloid and colloid bodies with immunofluorescence after pretreatmentsH Mukai, H Eto, S Nishiyama, et al.
International Journal of Pharmaceutics|September 16, 1999
Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist, at therapeutic doses in several animal species and interspecies scaling of its pharmacokinetic parametersH Mukai, S Watanabe, K Tsuchida, et al.
Protein and Peptide Letters|November 11, 2008
Elucidation of structural requirements of mastoparan for mast cell activation-toward the comprehensive prediction of cryptides acting on mast cellsH Mukai, Y Suzuki, Y Kiso, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|August 1, 1990
[The role of bacteria on facial rosacea-like dermatitis in adult type atopic dermatitis]T Noguchi, H Mukai, K Nishioka, et al.
Pageof 28